1,261 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVS Novartis AG $85.13 $197.65B Uptrend
Article Searches
Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend http://www.zacks.com/stock/news/342114/amgen-amgn-continues-to-reward-shareholders-ups-dividend?cid=CS-ZC-FT-342114 Dec 10, 2018 - Amgen (AMGN) hikes its quarterly dividend by 10%.
ADMP And Sandoz Announce Plans For SYMJEPI Launch https://seekingalpha.com/article/4227049-admp-sandoz-announce-plans-symjepi-launch?source=feed_sector_healthcare Dec 07, 2018 - Adamis and Sandoz announce an expected SYMJEPI launch in Q1 2019.Sandoz announces SYMJEPI’s WAC of $250 vs. $300 for Mylan’s and Teva’s generic EpiPen.Adamis has completed manufacturing, and is shippi
Conatus May Still Have A Path Forward After Latest Phase 2b Data https://seekingalpha.com/article/4226987-conatus-may-still-path-forward-latest-phase-2b-data?source=feed_sector_healthcare Dec 07, 2018 - Conatus Pharmaceuticals didn't meet primary endpoint for phase 2b ENCORE-PH study, but a subgroup analysis of compensated cirrhosis patients had a clinically meaningful effect when taking emricasan.Th
Novartis Presents Additional Data on Breast Cancer Candidate http://www.zacks.com/stock/news/341919/novartis-presents-additional-data-on-breast-cancer-candidate?cid=CS-ZC-FT-341919 Dec 07, 2018 - Novartis (NVS) presents supplementary data from phase III study on BYL719 in combination with Faslodex for the treatment of advanced breast cancer. The study scripts success in PFS.
Pharma Stock Roundup: Glaxo's TESARO Buyout & Horlicks Sale, ASH Cancer Data Updates http://www.zacks.com/stock/news/341786/pharma-stock-roundup-glaxos-tesaro-buyout-horlicks-sale-ash-cancer-data-updates?cid=CS-ZC-FT-341786 Dec 07, 2018 - Glaxo (GSK) to buy TESARO and divest Horlicks brand to Unilever. ASH cancer presentations grab headilines.
Celgene Doesn't Want To Be Left Out, Posts Promising JCAR017 Data https://seekingalpha.com/article/4226884-celgene-want-left-posts-promising-jcar017-data?source=feed_sector_healthcare Dec 06, 2018 - Celgene announces positive preliminary data from its study treating patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) using JCAR017.A key risk i
THW: Global Healthcare Fund With 10%+ Yield https://seekingalpha.com/article/4226785-thw-global-healthcare-fund-10-percent-yield?source=feed_tag_etf_portfolio_strategy Dec 06, 2018 - THW is a Tekla healthcare fund much like THQ, but with an emphasis on holding global securities.THW currently has a quite attractive 10.55% yield.This fund is also showing a discount of 8.29%, but tha
Eye Drug Continues to Drive Regeneron's Growth http://www.gurufocus.com/news/780907/eye-drug-continues-to-drive-regenerons-growth- Dec 04, 2018 - Eye Drug Continues to Drive Regeneron's Growth, Stocks: REGN,NVS,RHHBY,XTER:BAYN,IBB,RGNY,APLS,OPHT,AGN, release date:Dec 04, 2018
Incyte (INCY) Announces Positive Data on Jakafi for GVHD http://www.zacks.com/stock/news/341138/incyte-incy-announces-positive-data-on-jakafi-for-gvhd?cid=CS-ZC-FT-341138 Dec 04, 2018 - Incyte (INCY) announces positive data on lead drug Jakafi at the ASH meet for the indication of acute GVHD.
Gilead (GILD) Announces Data on CAR T Therapy Candidate http://www.zacks.com/stock/news/341121/gilead-gild-announces-data-on-car-t-therapy-candidate?cid=CS-ZC-FT-341121 Dec 04, 2018 - Gilead (GILD) announces data on chimeric antigen receptor T (CAR T) cell therapy candidate at the ASH for the treatment of patients with relapsed or refractory acute lymphoblastic leukemia.

Pages: 123456...127

Page 1>

Related Companies

Name Exchange Price Mkt Cap
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Novartis AG
NVS - Google Finance https://www.google.com/finance?q=NVS Industry related info and international coverage Summary News
NVS - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=NVS Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options